Background and Aim: Probiotics are beneficial microorganisms for humans and animals. In this study, we developed a microencapsulated probiotic with antibacterial activity against avian pathogenic Escherichia coli (APEC). Materials and Methods: Alignment of the 16S rRNA sequences of the isolate WU222001 with those deposited in GenBank revealed that the isolate was Pediococcus acidilactici with 99.6% homology. This bacterium was characterized as a probiotic based on its tolerance toward in vitro gastrointestinal tract (GIT) conditions, hydrophobicity, and auto-aggregation. The antibacterial activity of the probiotic’s culture supernatant against APEC was investigated using a broth microdilution assay. Pediococcus acidilactici was microencapsulated using sodium alginate and agar with diameters ranging from 47 to 61 µm. Then, physicochemical characteristics and stability of the microcapsules were determined. Results: The isolate was characterized as a probiotic based on its resistance to low pH, bile salts, and pancreatin, with relative values of 79.2%, 70.95%, and 90.64%, respectively. Furthermore, the bacterium exhibited 79.56% auto-aggregation and 55.25% hydrophobicity at 24 h. The probiotic’s culture supernatant exhibited strong antibacterial activity against clinical APEC isolates with minimum inhibitory concentration and minimum bactericidal concentration of 12.5% and 25% v/v, respectively. Microencapsulation-enhanced bacterial viability in GIT compared to free cells. Moreover, 89.65% of the encapsulated cells were released into the simulated intestinal fluid within 4 h. The viable count in microcapsules was 63.19% after 3 months of storage at 4°C. Conclusion: The results indicated that the culture supernatant of P. acidilactici inhibited the growth of APEC. In addition, microencapsulation extends the viability of P. acidilactici under harsh conditions, indicating its potential application in the feed production. Keywords: antibacterial activity, avian pathogenic Escherichia coli, microcapsule, microencapsulation, Pediococcus acidilactici, probiotics.

Background and Aim: Probiotic viability remains a critical challenge during gastrointestinal (GI) transit, storage, and feed processing. Conventional encapsulation materials often fail under acidic and thermal stress. This study aimed to develop and characterize a novel, eco-friendly microencapsulation system using Ficus pumila (FP) seed extract as a natural encapsulating matrix for Lacticaseibacillus paracasei (LP) WU2502, enhancing its functional resilience and storage stability. Materials and Methods: Microcapsules containing LP and FP were formulated through ionic gelation using calcium chloride. Physicochemical properties were assessed using scanning electron microscopy and Fourier-transform infrared (FTIR). Functional evaluations included encapsulation efficiency (EE), swelling kinetics, controlled release in simulated gastric and intestinal fluids, stress tolerance (acid, bile, enzymes, thermal), and viability during 60-day storage at 4°C and 25°C. Results: The LP/FP microcapsules demonstrated high EE (80.5%) and spherical morphology (~200 μm). FTIR confirmed the presence of ionic and hydrogen bonding in the matrix. The system exhibited pH-responsive swelling and controlled release, reaching 89.17% cumulative release in intestinal fluid. Encapsulated cells showed significantly improved tolerance to acidic pH, bile salts, digestive enzymes, and heat compared to free cells (p < 0.05). After 60 days, the viability of encapsulated cells remained above 60% at both storage temperatures, while free cell viability dropped by over 85%. Conclusion: FP seed extract offers a biodegradable, plant-derived alternative for probiotic encapsulation. The developed LP/FP system effectively enhances probiotic survival under GI and thermal stress and during extended storage. These results support its application as a sustainable delivery platform for animal feed and functional food formulations. Keywords: Ficus pumila, gastrointestinal stability, Lacticaseibacillus paracasei, plant-based matrix, probiotic microencapsulation, storage viability, thermal resistance.

Skin is the largest organ of the human body, serving as a protective barrier against various environmental factors, including sunlight, chemical agents, and pathogens. This study aimed to evaluate the clinical effects and moisturizing properties of a body lotion containing extracts of Stemona tuberosa and Aloe vera (BSAE) on human skin, as well as to assess the antibacterial effectiveness of the lotion against skin-infecting pathogens. A significant difference (P < 0.05) in the average water content of the epidermis was observed after volunteers used BSAE for 14 and 28 days, with values of 84.47 ± 1.28 and 100.82 ± 1.22, respectively. Additionally, transepidermal water loss at day 14 and day 28 was measured at 8.31 ± 1.31 and 6.83 ± 0.89, respectively. The melanin content in the volunteers significantly decreased after using BSAE for 14 days, showing a value of 269 ± 1.89 compared to a baseline value of 278.43 ± 1.03 at day zero (before use). Furthermore, Stemona tuberosa extract demonstrated an inhibitory effect on tyrosinase activity in vitro. The BSAE also exhibited antibacterial activity against Pseudomonas aeruginosa, with a minimum inhibitory concentration (MIC) value as 16 mg/mL. GC-MS analysis identified 5-Hydroxymethylfurfural as the primary phytochemical in Stemona tuberosa extract, followed by Hexadecanoic acid. These results suggest that BSAE may enhance water retention in the epidermis, reduce transepidermal water loss and melanin content, and inhibit the growth of P. aeruginosa.

Microencapsulation using polymer materials is a potent process to protect and prolong the survival of probiotics. Cissampelos pareira leaf contains natural gelling agents that possess solidifying properties. This study aimed to investigate the development of microencapsulation containing Lacticaseibacillus paracasei using C. pareira extract as a natural encapsulating material. The absorption bands near 1603 cm−1 and 1725 cm−1 detected by Infrared spectroscopy (FTIR) were identified as pectin in C. pareira structure. The L. paracasei-C. pareira microcapsules (LP-CP) showed high encapsulation efficiency by 90.5% which was confirmed by the evaluation of their survival rate. Under thermal conditions (85oC), bacterial viability detected in the microcapsules was 69% as opposed to non-encapsulated bacteria where viability was as low as 5%. Furthermore, the microcapsule presented 75% bacterial viability whereas the free cells showed 30% under acidic conditions (pH 2). During storage conditions, LP-CP viability remained at 50% when the storage time was extended to 90 days whereas, the survival rate of free cells significantly decreased by 100% after 90 days. This information suggests that C. pareira is a potent polymer which can be used as an eco-friendly material for the microencapsulation of probiotics relevant as dietary supplementation for humans or animals.